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Abstract
Objective: Hip fracture tremendously impacts functional abilities for the elderly with high morbidity and
mortality; recovery is compromised by co-morbidities. Diabetes mellitus is a common co-morbidity for the aging
population, but little is known about the influence of diabetes on outcomes of the Asian elderly with hip fracture.
Research Design and Methods: This study was a secondary analysis of data on 242 community-dwelling elders
with hip fracture from three previous longitudinal studies. Sixty-one cases (25.2%) had diabetes. Outcomes were
measured by the Chinese Barthel Index, Medical Outcomes Study Short Form-36 Taiwan version, and analyzed
by the generalized estimating equation approach to examine how diabetes influenced hip-fractured elders’
mortality, service utilization, mobility, daily activities, and health-related quality of life during the first 12
months after postsurgical discharge in Taiwan.
Results: Hip-fractured elderly with diabetes had a significantly higher mortality rate (22.6% vs. 10.3%, p = 0.03)
during the first year following discharge, and significantly higher readmission rate (10.0% vs. 2.5%, p = 0.04)
from the first to third month following discharge than those without diabetes. After controlling for covariates,
elderly participants without diabetes had an overall 2.2 times (confidence interval [CI] = 1.15–4.21) greater odds
of recovery in walking ability and better reported general health (b = 9.33; p = 0.01) and physical functioning
(b = 7.26; p = 0.02) than those with diabetes during the first year after discharge.
Conclusions: Diabetes negatively influenced outcomes of elderly patients with hip fracture. The results may
provide a reference for developing interventions for hip-fractured elders with diabetes.
Introduction
Hip fracture usually impacts on functional activitiesand walking ability of the elderly and contributes to
high morbidity and mortality.1 Even for hip-fractured elders
undergoing surgery, the mortality rate within 1 year was
16.3%–25.3%,2,3 and only 40%–56.1% recovered their previ-
ous physical function after 1 year.3,4 The incidence of hip
fracture increases with increasing age.5 With the global
population aging, the incidence of hip fracture is expected to
reach 6.26 million by 2050.6 In Taiwan, the population age
‡ 65 years was 10.6% in 2009 and is expected to reach 41.6%
by 2060.7 Because Taiwan has the highest age-standardized
hip fracture rate in Asia,8 hip fracture in the elderly has be-
come a major concern in Taiwan.
In Taiwan, 72.4% of the elderly suffered at least one
chronic disease and about 50% suffered two concurrently9;
predictably, co-morbidity will negatively influence outcomes
of the hip-fractured elderly. Among co-morbidities in Tai-
wan, diabetes mellitus (DM) was the fifth leading cause of
death in 2010, with its prevalence increasing annually and
with age.10 Moreover, 18% of the Taiwanese elderly (age ‡ 65
years) suffer from DM and the majority have type 2 diabetes
(T2DM).11
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Elders with diabetes have been shown to have a higher
incidence of hip fracture than those without diabetes, and
this incidence is related to the duration of DM, its compli-
cations, and the use of insulin.12–21 However, few studies
have explored the influence of DM on outcomes after hip
fracture, with inconsistent findings.22–28 One study found
that among hip-fractured elders, those with diabetes (n = 69)
had significantly higher mortality than those without dia-
betes (n = 161) (32% vs. 12.7%) 1 year after fracture, and
mortality was related to their age, postsurgical complica-
tions, and elevated glycosylated hemoglobin level.22 A sec-
ondary analysis of data classified 79,526 hip-fractured elders
from 915 rehabilitation facilities in the United States into
three groups: No DM (77%), non-tier diabetes (18.3%), and
tier DM (4.7%).23 The tier DM group had longer lengths of
hospital stay, worse functional status, and lower odds of
discharge home, and the influence of DM on recovery from
hip fracture was moderated by age.23 Another study also
demonstrated that diabetic patients with hip fracture had
longer lengths of hospital stay and recovered function more
slowly.24
However, one study25 found that DM did not influence
the mobility or functional ability of the elderly with hip
fracture at discharge, but they had higher mortality during
hospitalization. Even after undergoing rehabilitation, hip-
fractured elders with diabetes still had higher mortality than
those without DM after 1 year.26 Similarly, after an average
23 days rehabilitation, hip-fractured elderly with DM
(n = 224) had significantly poorer physical function than
those without DM (n = 738).27 In contrast, hip-fractured
elders with DM (n = 138) in another study,28 after an average
29.6 – 14.2 days of rehabilitation, had significantly better
physical function than those without DM (n = 621), but
their functional gain during rehabilitation did not differ
significantly.
Thus, information on how DM influences the outcomes
and recovery trajectory after hip fracture is limited and in-
consistent. Previous studies focused mostly on exploring
mortality and physical function, with little emphasis on other
aspects of health outcomes, such as quality of life. Besides,
the longitudinal influence of DM on outcomes is still unclear;
no studies have explored whether the impact of DM on
health outcomes following hip fracture is steady over time
and how long the impact lasts. Finally, no studies have ex-
amined this phenomenon in Asian or Chinese elders.
Therefore, the purpose of this study was to explore and
compare the 1-year trajectories in physical functioning,
health outcomes, and quality of life for hip-fractured elders
with and without DM in Taiwan.
Methods
Study setting and sample
The sample for this study was drawn from three prior
studies on hip-fractured elders in Taiwan.29–31 The first
subsample (n = 110) was drawn from an observational study
(1999–2001),29 and two subsamples were drawn from the
control groups of two clinical trials (n = 82, 50, respectively,
conducted from 2001 to 2004, 2005 to 2009).30,31 All data
were collected at the same time points, and all participants
were recruited from the same orthopedic wards of a 3,800-
bed medical center in northern Taiwan with similar criteria:
(1) Age ‡ 60 years, (2) hospitalized due to hip fracture and
received surgery, (3) living in northern Taiwan, and (4)
Chinese Mini-Mental State Examination (CMMSE) score ‡ 10,
indicating without severe cognitive impairment.32 The three
subsamples differed due to participants from the two clinical
trials being required to have a prefracture Chinese Barthel
Index (CBI) score > 70, so they might have had better pre-
fracture performance of activities of daily living (ADLs) than
those from the observation study. Furthermore, although all
participants received the same care after hip surgery on the
same hospital wards, participants in the later studies might
have received better care because of improvements in routine
care. To reduce bias, participants’ membership among the
three studies and their prefracture ADL performance were
controlled in the analysis. In the final sample (n = 242), 61
(25.2%) elders had DM and the remaining 181 (74.8%) elders
did not.
Procedures
All three studies were approved by the Committee on
Human Research at the hospital and were implemented by
the same procedure. Researchers identified and invited eli-
gible participants to take part in each study before their
discharge. Every participant signed informed consent and
was assessed five times—before discharge and at 1, 3, 6,
and 12 months after discharge—by face-to-face interviews
and observations. Demographic data and cognitive function
were obtained before discharge as covariates.
Outcome measures
Recovery in performing ADLs. Walking, bathing, climb-
ing stairs, transferring, grooming, and eating were measured
by the CBI.33 The CBI, with scores ranging from 0 to 100, has
had satisfactory reliability and validity for assessing frail
elders in Taiwan.33 Recovery in ADL performance was rated
by comparing it with prefracture ADL performance (rated at
admission by the CBI via participants’ self-report and vali-
dated by family members); scores reaching the prefracture
level were coded as 1, and those less than the prefracture
level were coded as 0.3 Some ADLs, such as walking and
transferring, were rated by actually observing participants’
performance. The ADLs of eating and toileting were rated by
asking participants/family members.
Recovery in walking ability. Walking ability was assessed
by the CBI item that assesses independence in walking.3 The
participants were asked to walk for 50 yards and were rated
0 (immobile or < 50 yards), 5 (wheelchair independent, in-
cluding corners, > 50 yards), 10 (walks with verbal or
physical help of one person, > 50 yards), and 15 (indepen-
dent, but may use any aid, e.g., a cane, > 50 yards). Pre-
fracture walking ability was collected retrospectively at
admission, and was compared with postfracture walking
ability. If the score of postfracture walking ability was
greater than or equal to the score of prefracture, the recovery
in walking ability was coded as 1; if not, the recovery was
coded as 0.3
Health-related quality of life (HRQoL). This was assessed
by the Taiwan version of the Medical Outcomes Study Short
Form-36 (SF-36).34–36 The SF-36 consists of 36 items
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representing eight dimensions, including physical function-
ing, role disability due to physical health problems, bodily
pain, vitality, general health perceptions, social functioning,
role disability due to emotional problems, and general mental
health. For each subscale (dimension), the score ranges from 0
to 100, with higher scores representing better health outcomes.
Data analysis
The generalized estimating equations (GEE) approach was
used to determine whether DM influenced the recovery of
elders in performance of ADLs, walking ability, and HRQoL
during the first 12 months after discharge for hip fracture.
This approach can account for possible correlations and ex-
plore differences in repeated measurements over time; an-
other advantage is that it can utilize partial information, e.g.,
participants with incomplete data can still contribute to the
estimation parameters.37,38 Therefore, this approach is espe-
cially useful in longitudinal studies in which sample attrition
is inevitable. Thus, in our GEE analysis, data from the elders
who died or dropped out within 1 year following discharge
(n = 70) were also included. The GEE modeled dependent
dichotomous variables (recovery/no recovery in overall
ADL performance and walking ability) and dependent con-
tinuous variables (HRQoL measured by the SF-36)—time,
gender, age, number of other co-morbidities (obtained from
medical records or self-report of elders/families), type of
surgery (internal fixation or arthroplasty), prefracture ADL
performance, data set membership, and with or without DM
were treated as independent variables. All data were ana-
lyzed by SAS software (SAS Institute, Inc., Cary, NC).
Elders who gradually dropped out (n = 70) during the
study period, and those who remained in the study did not
differ significantly in demographic or outcome variables at
the first month, except that those who dropped out were
older ( p = 0.001). The major reasons for dropping out were
losing contact due to change of address or refusal to continue
participating, i.e., not related to participants’ mortality or
health conditions. Thus, age was controlled as a covariate,
and all participants were included in the analysis.
Results
Sample characteristics
Demographic and clinical characteristics of participants
with (n = 61, 25.2%) and without DM (n = 181, 74.8%) are
listed in Table 1. The sample was predominantly female
(n = 153, 63.2%), had a mean age of 78.9 years (standard
deviation [SD] = 7.56, range = 63–96), and the majority
(n = 145, 59.9%) had no formal education. The majority of
participants (n = 153, 63.2%) underwent internal fixation,
and the average length of hospital stay was 10.6 days
(SD = 5.3). The mean prefracture ADL performance was
96.2 (SD = 9.0), with no significant difference between
elders with and without DM, indicating that elders in both
groups were relatively independent before hip fracture.
During the first year after discharge, 27 (11.2%) participants
died, with 9 (3.7%) dying within the first month, 8 (3.3%)
between months 1 and 3, 3 (1.2%) between months 3 and 6,
and 7 (2.9%) between months 6 and 12. In addition, 43 par-
ticipants dropped out during the first year. Of these dropouts,
8 (3.3%) dropped out in the first month, 8 (3.3%) between
months 1 and 3, 8 (3.3%) between months 3 and 6, and 19
(7.9%) between months 6 and 12. Participants who with or
without DM did not differ significantly in most characteristic
variables, except that those with DM had significantly more
(t = 7.89, p < 0.001) co-morbidities (M = 2.41, SD = 1.22) than
those without DM (M = 1.05, SD = 0.96).
Difference in mortality and service utilization
Within the first year following discharge, hip-fractured
elderly with DM had a significantly higher (v2 = 5.07,
p = 0.03) mortality rate (n = 12, 22.6%) than those without
DM (n = 15, 10.3%). For readmission rate, elders with DM
had a significantly higher (v2 = 5.22, p = 0.04) rate (n = 5,
10.1%) than those without DM (n = 4, 2.5%) only during the
first to third month after discharge. However, the rates of
emergency room visits and institutionalization did not
differ significantly at any time point between elders with
and without DM (Table 2).
Table 1. Demographic and Clinical Characteristics of Elders with and without Diabetes Mellitus
Characteristic With DM (n = 61) Without DM (n = 181) p
Age (years), mean – SD 77.34 – 7.37 79.44 – 7.57 0.06
Gender, n (%) 0.22
Male 18 (29.5) 71 (39.2)
Female 43 (70.5) 110 (60.8)
Hospital stay (days), mean – SD 11.72 – 5.87 10.23 – 5.08 0.08
Educational background, n (%) 0.84
Illiterate 35 (57.4) 110 (60.8)
Primary school 17 (27.9) 41 (22.7)
High school 6 (9.8) 22 (12.2)
College or above 3 (4.9) 8 (4.4)
Type of surgery, n (%) 0.45
Arthroplasty 25 (41) 64 (35.4)
Internal fixation 36 (59) 117 (64.6)
Number of co-morbidities, mean – SD 2.41 – 1.22 1.05 – 0.96 < 0.001*
Prefracture ADL performance, mean – SD 94.43 – 12.69 96.77 – 7.30 0.21
DM, Diabetes mellitus; SD, standard deviation; ADL, activities of daily living.
*p < 0.001.
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The influence of DM on physical function recovery
and HRQoL
The clinical outcomes (recovery rates for ADL perfor-
mance and walking ability, scores for various dimensions of
HRQoL) for hip-fractured elders with and without DM at
various times after hospital discharge are presented in Table
2. After controlling for prefracture ADL performance (CBI
score) as a covariate in analysis, elders with DM had sig-
nificantly poorer recovery in ADL performance, walking
ability (Fig. 1), and most dimensions of HRQoL during the
first 6 months following discharge.
Further GEE analysis (Table 3) showed the trends in re-
covery for all elders. Compared to their performances in the
first month, all elders significantly improved 3, 6, and 12
months after discharge, as shown in their recovery trends.
Moreover, the GEE analysis showed the negative influence
of DM during the first year after discharge. Elders without
DM had significantly better recovery (b = 0.79; p = 0.02) and a
2.2 times (CI = 1.15–4.21) greater odds of recovering their
walking ability than those with DM, but the two groups did
not differ significantly in recovery of ADL performance.
Regarding the influence of DM on recovery trajectories of
HRQoL, elders without DM had significantly better health
outcomes than those with DM in general health (b = 9.33;
p = 0.01) and physical functioning (b = 7.26; p = 0.02) during
the first year, but the two groups did not differ significantly
in other dimensions of HRQoL.
Discussion
This is the first longitudinal study to evaluate the impact
of DM on both physical recovery and HRQoL in Asian elders
following hip fracture. We found that DM negatively im-
pacts the recovery of ADL performance, walking ability, and
various health outcomes, especially during the first 6 months
following discharge. This finding is consistent with previous
reports23,27 that physical function after hip fracture is poorer
in patients with DM than those without DM, with similar
findings on the magnitude of influencing effects. We also
Table 2. Differences in Clinical Outcomes
after Hospital Discharge between Elders





(n = 181) p
Mortality, n (%)
Within month 1 2 (3.4) 7 (4.0) 1.00
Within month 3 6 (10.5) 11 (6.5) 0.38
Within month 6 7 (12.5) 13 (8.0) 0.42
Within month 12 12 (22.6) 15 (10.3) 0.03*
ER visits, n (%)
Within month 1 4 (7.3) 16 (9.5) 0.79
Months 1–3 3 (6.0) 8 (5.0) 0.73
Months 3–6 7 (14.0) 13 (8.8) 0.29
Months 6–12 6 (14.3) 7 (5.3) 0.09
Readmission, n (%)
Within month 1 8 (14.3) 15 (8.9) 0.31
Months 1–3 5 (10.0) 4 (2.5) 0.04*
Months 3–6 8 (16.3) 11 (7.5) 0.09
Months 6–12 6 (14.3) 12 (9.2) 0.39
Institutionalization, n (%)
Within month 1 7 (12.5) 8 (4.7) 0.06
Months 1–3 5 (9.1) 7 (4.3) 0.19
Months 3–6 4 (7.8) 3 (2.0) 0.07
Months 6–12 2 (4.9) 3 (2.3) 0.60
ADL recovery, n (%)
Month 1 2 (3.6) 10 (6.0) 0.74
Month 3 6 (12.0) 35 (22.3) 0.15
Month 6 12 (24.0) 63 (42.9) 0.02*
Month 12 21 (51.2) 73 (56.2) 0.59
Walking ability recovery, n (%)
Month 1 12 (21.8) 71 (42.8) 0.006{
Month 3 21 (42.0) 104 (66.2) 0.003{
Month 6 27 (54.0) 106 (72.1) 0.023*
Month 12 29 (70.7) 95 (73.1) 0.840
BP, mean – SD
Month 1 62.06 – 26.47 61.78 – 23.77 0.95
Month 3 63.07 – 26.95 73.18 – 22.81 0.02*
Month 6 74.00 – 31.81 74.08 – 24.81 0.99
Month 12 77.29 – 24.39 72.27 – 26.14 0.36
GH, mean – SD
Month 1 42.54 – 25.40 58.97 – 22.11 < 0.001{
Month 3 42.36 – 23.41 58.84 – 23.47 < 0.001{
Month 6 43.15 – 24.73 55.53 – 22.97 0.004{
Month 12 46.93 – 26.00 51.43 – 24.82 0.39
VT, mean – SD
Month 1 47.08 – 26.31 54.24 – 24.19 0.08
Month 3 50.12 – 19.30 61.80 – 21.06 0.002{
Month 6 56.67 – 22.86 62.66 – 19.56 0.11
Month 12 55.54 – 21.70 59.54 – 21.21 0.38
SF, mean – SD
Month 1 51.30 – 30.21 52.86 – 30.23 0.76
Month 3 55.95 – 28.19 61.71 – 27.36 0.24
Month 6 60.26 – 31.00 68.13 – 28.56 0.14
Month 12 69.40 – 28.07 69.14 – 29.67 0.97
RE, mean – SD
Month 1 54.17 – 45.93 59.43 – 45.38 0.49
Month 3 66.67 – 44.78 82.16 – 35.21 0.04*
Month 6 72.65 – 41.80 63.21 – 34.44 0.16
Month 12 79.77 – 39.90 87.04 – 31.85 0.38
MH, mean – SD
Month 1 51.67 – 23.22 59.45 – 21.18 0.03*
Month 3 60.57 – 22.01 66.90 – 19.84 0.08
Month 6 64.21 – 21.34 67.16 – 19.70 0.42







(n = 181) p
PF, mean – SD
Month 1 10.83 – 15.65 15.00 – 18.97 0.17
Month 3 20.60 – 22.26 30.87 – 26.43 0.02*
Month 6 31.38 – 23.18 42.48 – 28.73 0.03*
Month 12 35.67 – 28.73 47.66 – 31.50 0.06
RP, mean – SD
Month 1 12.5 – 31.37 11.02 – 28.15 0.76
Month 3 15.48 – 28.13 26.58 – 38.50 0.04*
Month 6 30.00 – 38.48 31.15 – 40.11 0.87
Month 12 44.83 – 48.36 42.27 – 43.47 0.78
*p < 0.05; {p < 0.01; {p < 0.001.
DM, diabetes mellitus; ER, emergency room; ADL, Activities of
daily living; BP, bodily pain; SD, standard deviation; GH, general
health perceptions; VT, vitality; SF, social functioning; RE, role
limitations due to emotional problems; MH, general mental health;
PF, physical functioning; RP, role limitations due to physical health
problems.
DIABETES AND RECOVERY FOLLOWING HIP FRACTURE 479
found that hip-fractured elders with DM had more co-
morbidities and higher mortality than those without DM, as
previously reported.22,28 In addition, we found that hip-
fractured elders with DM had a higher readmission rate
during the first 3 months following discharge. Unfortunately,
we did not have enough information on the reasons for
readmission to determine if readmissions were related to DM
or not.
However, we found that outcomes in both physical
recovery and HRQoL did not significantly differ between
elders with and without DM in the 12 months after fracture.
Hip-fractured elders with DM seemed to have greater im-
provement in recovery during the 6th to 12th months after
discharge, suggesting that DM mainly negatively influenced
hip-fractured elders during the first 6 months after surgery,
with its influence gradually diminishing thereafter. This
phenomenon might be due to the majority of the elders in
our research (n = 132, from two clinical trials) having good
prefracture functional abilities and cognitive function, so
they gradually recovered well after a long time. Never-
theless, we do not think that the outcomes of recovery in
elders with or without DM will finally reach the same
levels. We believe that the elders with DM still needed more
care during the recovery period, especially during the first
FIG. 1. Recovery in walking ability between diabetes mellitus (DM) and without-DM groups.
Table 3. Generalized Estimating Equations Analysis of Influence of Diabetes Mellitus
on Recovery in Physical and Mental Functioning During the First Year after Discharge
Time after discharge (months)
Outcome variable 3 6 12 With vs. without DM
ADL recovery 1.55{ 2.53{ 3.22{ 0.39
(OR = 4.71) (OR = 12.55) (OR = 25.03) (OR = 1.48)
(CI = 2.47–9) (CI = 6.32–24.93) (CI = 11.88–52.71) (CI = 0.7–3.11)
Walking recovery 0.98{ 1.28{ 1.63{ 0.79*
(OR = 2.66) (OR = 3.59) (OR = 5.11) (OR = 2.2)
(CI = 1.88–3.75) (CI = 2.45–5.27) (CI = 3.31–7.87) (CI = 1.15–4.21)
BP 7.93{ 10.99{ 11.67{ 1.26
GH - 1.89 - 4.59* - 5.92* 9.33{
VT 5.53{ 6.93{ 3.75 5.57
SF 8.18{ 13.09{ 17.99{ 1.28
RE 19.35{ 19.53{ 26.36{ 7.31
MH 7.21{ 7.23{ 6.07{ 3.81
PF 13.80{ 23.65{ 29.33{ 7.26*
RP 12.78{ 19.35{ 31.19{ 4.09
Time uses 1-month data as baseline. With versus without DM uses DM group data as baseline. Regression coefficients were obtained after
controlling for time, gender, age, number of co-morbidities, type of surgery, education, prefracture ADL, and dataset membership. Odds
ratios were calculated only for categorical outcome variables.
*p < 0.05; {p < 0.01; {p < 0.001.
DM, Diabetes mellitus; ADL, activities of daily living; OR, odds ratio; CI, confidence interval; BP , bodily pain; GH, general health
perceptions; VT, vitality; SF, social functioning; RE, role limitations due to emotional problems; MH, general mental health; PF, physical
functioning; RP, role limitations due to physical health problems.
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6 months after their discharge. The higher readmission rate
and less recovery in ADL performance and walking ability of
elders with DM will influence their quality of life and result
in higher mortality after discharge. These findings cannot be
ignored.
Our results add to the relevant literature by clarifying the
trajectory of functional recovery after hip fracture in elders
with and without DM. This trajectory had not clearly been
explored in previous studies, possibly due to different ap-
proaches to data analysis and the duration of follow-up.
Our findings highlight that, although hip-fractured elders
with DM had worse recovery after discharge than those
without DM, after a long period of time, hip-fractured elders
with DM might still recover as well as those without DM.
This result reminds clinicians to pay more attention to hip-
fractured elders with DM, especially during the first 6
months after discharge. Intervention protocols, particularly
for recovery in mobility, ADLs, and various functional out-
comes may need to be developed for these elders.
This study compared longitudinal changes in HRQoL and
physical recovery in a Taiwanese sample of elderly hip-
fractured patients with and without DM. The generalizabil-
ity of the study findings is limited by possible influencing
factors for which we did not collect data. For example, we
did not collect data on factors such as time since diagnosis
with DM, severity of DM, whether participants used a
medication or insulin, and how well DM was controlled. The
generalizability might also have been limited by participant
attrition (n = 70, 29%). Moreover, the results might have been
biased by obtaining participants’ prefracture ADL perfor-
mance from their recall, although it was validated by family
members. Because participants’ prefracture HRQoL was not
measured, we cannot precisely know if the health status of
elders with and without DM was similar before hip fracture
or they had a worse start after discharge. However, any
differences in the prefracture condition of both groups might
have been minimized by controlling their prefracture CBI
scores as a covariate in the analysis. In addition, due to the
sample selection criteria, the participants in this study may
have been relatively more independent before hip fracture
than the general population of hip-fractured elders. Elders
with severe cognitive impairment and physical disability
before fracture were also excluded from the study. All of
these were limitations of this research. Thus, the findings can
only be generalized to elders in Taiwan who were inde-
pendent before hip fracture.
These study results raise several issues. Does the length of
DM history influence recovery after hip fracture? How do
severity and complications of DM influence outcomes fol-
lowing hip fracture? These questions could be further ex-
plored and could serve as the foundation for interventional
studies.
Conclusion
DM negatively impacted the recovery of outcomes in
Taiwanese elders following hip fracture. DM not only
influenced their mortality and physical functions, but also
compromised their recovery of ADL performance, walking
ability, and various dimensions of HRQoL, although the
influences of DM seemed to gradually diminish in some
health dimensions. Because the elderly Asian population is
rapidly growing in Western countries,39 the results of this
study could provide a reference for health-care providers in
countries that have to deal with elderly Chinese/Taiwanese
hip-fractured elders with DM.
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